Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis Nature.com 04:49 Sat, 02 May
Reduced type 2 epithelial-mesenchymal transition serves as a risk factor for the progression from endometriosis to endometriosis-associated ovarian cancer Nature.com 12:22 Fri, 01 May
One person dying every three days 'because of talc baby powder' court told Essex Live 12:45 Wed, 29 Apr
Rising bowel and ovarian cancer rates in younger adults raise new concerns News-Medical.Net 03:07 Wed, 29 Apr
Ovarian Cancer Incidence, Mortality Elevated in High Radon Zone Oncology Nurse Advisor 14:43 Mon, 27 Apr
Epitopea receives MHRA approval for first-in-human trial of RNA vaccine for ovarian cancer Manufacturing Chemist 10:15 Mon, 27 Apr
Innate immunity and lipids: resistance to immunotherapy in the peritoneal cavity Behavioural and Social Sciences at Nature Research 00:51 Sun, 26 Apr
A machine learning-driven framework integrating cell death and senescence signatures for multi-target drug design and immunotherapy optimization in ovarian cancer Nature.com 00:13 Sun, 26 Apr
Epitopea receives MHRA and REC approvals for OVACT ovarian cancer trial Clinical Trials Arena 15:59 Fri, 24 Apr
New KIR-CAR T Cell Therapy Shows Promise in Multiple Solid Cancers Newswise (Press Release) 18:21 Mon, 20 Apr
Deconstructing the rage signaling maze: the molecular key to opening a new dimension of ovarian anti-aging Nature.com 04:55 Mon, 20 Apr
Breakthrough tool may help doctors find ovarian cancer before it spreads Knowridge Science Report 01:58 Mon, 20 Apr
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents Medpage Today 20:16 Thu, 16 Apr
Extracellular vesicle delivery of Myricetin suppresses ovarian cancer through mitochondrial dynamics by downregulating the ECM1/Nf-κB/TGFβ signaling pathway Nature.com 03:32 Thu, 16 Apr
Targeting senescent ADSCs in adipose tissue: University team paves new way for ovarian cancer therapy ecancer 16:10 Tue, 14 Apr
Targeting senescent fat cells provides new hope for ovarian cancer News-Medical.Net 18:24 Mon, 13 Apr
AbbVie’s Elahere succeeds in Phase II platinum-sensitive ovarian cancer trial Clinical Trials Arena 17:20 Mon, 13 Apr
Landmark Study Led by Roswell Park Expert Shows Survival Benefit of Immunotherapy in Resistant Ovarian Cancer Newswise (Press Release) 13:39 Mon, 13 Apr
Tiny camera could help detect ovarian cancer earlier than ever before Knowridge Science Report 11:43 Mon, 13 Apr
Chemo Combo Wins in Ovarian Cancer, But Single-Agent Therapy Still in the Game Medpage Today 16:42 Sun, 12 Apr
AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026 AbbVie (Press Release) 12:20 Sun, 12 Apr
Novel Regimen Boosts Survival for Recurrent Platinum-Resistant Ovarian Cancer Medpage Today 00:33 Sun, 12 Apr
Ovarian cancer breakthrough as patients who take pill 'less likely to die' The Mirror 08:25 Sat, 11 Apr Article paywall
Radon and Ovarian Cancer; FDA Rejects Drug Again; Missed Chances for Genomic Testing Medpage Today 20:04 Fri, 10 Apr
Verastem Oncology’s combo shows two-year durability in ovarian cancer Clinical Trials Arena 18:08 Fri, 10 Apr
Insilico announces ISM6200 AI-designed drug candidate for ovarian cancer and cortisol disorders Drug Target Review 13:03 Fri, 10 Apr
Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancer Nature.com 03:23 Fri, 10 Apr
Insilico Medicine nominates AI-driven drug candidate for cancer, Cushing's syndrome and obesity News-Medical.Net 19:14 Wed, 08 Apr
